Research innovations from CPC investigators
Members of the Cancer Prevention and Control research program at IU Simon Comprehensive Cancer Center are leading remarkable laboratory and clinical studies that reduce the burden of cancer.
Ballinger TJ, et al. Impact of African ancestry on the relationship between body mass index and survival in an early-stage breast cancer trial (ECOG-ACRIN E5103). Cancer. 2022 Mar 14.
Kasting ML, et al. A National Survey of Obstetrician/Gynecologists' Knowledge, Attitudes, and Beliefs Regarding Adult Human Papillomavirus Vaccination. J Womens Health (Larchmt). 2021 Oct;30(10):1476-1484. doi: 10.1089/jwh.2020.8727.
Rawl SM, et al. Partnering to Increase Colorectal Cancer Screening: Perspectives of Community Advisory Board Members. West J Nurs Res. 2021 Oct;43(10):930-938.
Rawl SM, et al. Computer-tailored intervention increases colorectal cancer screening among low-income African Americans in primary care: Results of a randomized trial. Prev Med. 2021 Apr;145:106449.
Zimet GD, et al. Adolescent Consent for Human Papillomavirus Vaccine: Ethical, Legal, and Practical Considerations. J Pediatr. 2021 Apr;231:24-30. doi: 10.1016/j.jpeds.2021.01.026.
American Society of Clinical Oncology 2021 Annual Meeting:
Guiding drug therapy using patient genetics
CPC members Tyler Shugg, PhD, Zeruesenay Desta, PhD, Bryan Schneider, MD, and Todd Skaar, PhD, are making an impact along with other colleagues from Indiana University School of Medicine.
Their study using patient genetics to guide drug therapy and manage drug interactions that could potentially benefit patients with advanced cancer was recently published in the renowned journal JCO Precision Oncology.
